New York Mortgage Trust Reports First Quarter 2018 Results
May 03, 2018 20:02 pm UTC| Business
NEW YORK, May 03, 2018 -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three months ended March 31, 2018. Summary of First Quarter 2018: Net...
Editas Medicine Announces First Quarter 2018 Results and Update
May 03, 2018 20:02 pm UTC| Business
Expanded Celgene collaboration to drive lead oncology program in solid tumors Strengthened Board of Directors with addition of James C. Mullen and Jessica Hopfield, Ph.D. Cash, cash equivalents, and marketable...
May 03, 2018 20:02 pm UTC| Business
-- Sarepta strengthens position as a leader in gene therapy; expands rare disease franchise -- -- The program is designed, if successful, to offer first-ever corrective treatments for five distinct forms of Limb-girdle...
Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03, 2018 20:02 pm UTC| Business
FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018Lebrikizumab Phase 2b study enrolling patients, data expected in first half of 2019 MENLO PARK, Calif., May 03, 2018 -- Dermira,...
NewLink Genetics Reports First Quarter 2018 Financial Results
May 03, 2018 20:02 pm UTC| Business
AMES, Iowa, May 03, 2018 -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the first quarter 2018 and reviewed recent highlights and upcoming milestones. “NewLink Genetics...
Allscripts announces first quarter 2018 results
May 03, 2018 20:02 pm UTC| Business
Reported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to...
AveXis Reports First Quarter 2018 Financial and Operating Results
May 03, 2018 20:02 pm UTC| Business
-- Significant progress across operating functions including licensing, clinical trials and regulatory interactions -- -- AVXS-101 pre-BLA meeting with FDA is scheduled to be held in June 2018 -- CHICAGO, May 03, 2018 ...